|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | |
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61K 31/519 | |||
| A61P 37/00 |
| (11) | Number of the document | 2914343 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13792152.4 |
| Date of filing the European patent application | 2013-11-01 | |
| (97) | Date of publication of the European application | 2015-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/067956 |
| Date | 2013-11-01 |
| (87) | Number | WO 2014/071125 |
| Date | 2014-05-08 |
| (30) | Number | Date | Country code |
| CH45952012 | 2012-11-02 | IN | |
| 201361771812 P | 2013-03-02 | US |
| (72) |
WEISS, Michael, US
MISKIN, Hari, US
SPORTELLI, Peter, US
VAKKALANKA, Swaroop K.V.S., CH
|
| (73) |
Laboratoire Franēais du Fractionnement et des Biotechnologies,
3, Avenue des Tropiques ZA de Courtaboeuf, 91940 Les Ulis,
FR
Rhizen Pharmaceuticals S.A., Fritz Courvoisier 40, 2300 La Chaux de Fonds, CH TG Therapeutics, Inc., 2 Gansevoort St., 9th Floor, New York, NY 10014, US |
| (54) | COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR |
| COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR |